CJC-1295 With DAC

CJC-1295 with DAC is a modified GHRH analogue engineered with a Drug Affinity Complex (DAC) intended to extend functional half-life through albumin association. This long-acting design supports sustained receptor engagement and is frequently used in endocrine research where longer signalling windows are desirable. Studies examine how prolonged GHRH receptor activation influences GH secretion patterns, downstream IGF-1 signalling, and endocrine feedback regulation. Research commonly tracks biomarker trajectories over extended time windows to characterise amplitude, duration, and stability of GH-axis modulation compared with shorter-acting GHRH analogues.

‍

‍

‍

‍